Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:35:30 EDT Mon 30 Jun 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:BNGO
- BIONANO GENOMICS INC -
https://bionanogenomics.com/
18:35:30 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
BNGO
- Q
0.5
3.27
·
3.31
0.1
3.28
-0.01
-0.3
45.6
124
647
3.31
3.40
3.274
44.9399 2.68
18:05:28
Jun 18
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 647
More trades...
Time ET
Ex
Price
Change
Volume
18:05:28
Q
3.31
0.02
10
17:56:30
Q
3.30
0.01
1
17:38:00
Q
3.30
0.01
2
17:27:38
Q
3.26
-0.03
3
17:25:38
Q
3.30
0.01
1
16:59:17
Q
3.30
0.01
4
16:54:42
Q
3.46
0.17
1
16:54:36
Q
3.30
0.01
2
16:47:13
Q
3.28
-0.01
3
16:38:24
Q
3.30
0.01
100
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-18 08:00
U:BNGO
News Release
200
Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy
2025-05-14 16:01
U:BNGO
News Release
200
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
2025-05-07 16:01
U:BNGO
News Release
200
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
2025-04-23 08:00
U:BNGO
News Release
200
Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease
2025-04-08 08:00
U:BNGO
News Release
200
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
2025-03-31 16:01
U:BNGO
News Release
200
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
2025-03-24 08:00
U:BNGO
News Release
200
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect
2025-03-18 08:00
U:BNGO
News Release
200
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting
2025-03-14 08:00
U:BNGO
News Release
200
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025
2025-03-13 09:00
U:BNGO
News Release
200
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
2025-01-22 16:05
U:BNGO
News Release
200
Bionano Announces Effective Date of Reverse Stock Split
2025-01-14 08:00
U:BNGO
News Release
200
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss
2025-01-13 08:00
U:BNGO
News Release
200
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
2025-01-07 08:00
U:BNGO
News Release
200
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia
2025-01-06 16:30
U:BNGO
News Release
200
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2025-01-03 14:34
U:BNGO
News Release
200
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2024-12-31 15:26
U:BNGO
News Release
200
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway
2024-12-23 08:30
U:BNGO
News Release
200
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis
2024-12-19 08:00
U:BNGO
News Release
200
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
2024-12-10 08:00
U:BNGO
News Release
200
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy